{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:33:15Z","timestamp":1791419595871,"version":"4.3.3"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Aortic stenosis (AS) is a progressive disease, with no pharmacological treatment. The prevalence of diabetes mellitus (DM) among AS patients is higher than in the general population. DM significantly increases the risk of AS development and progression from mild to severe. The interplay between AS and DM's mechanism is not entirely known yet.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main Body<\/jats:title>\n                <jats:p>The increased accumulation of advanced glycation end products (AGEs) was linked to increased valvular oxidative stress, inflammation, expression of coagulation factors, and signs of calcification, according to an analysis of aortic stenotic valves. It is interesting to note that in diabetic AS patients, valvular inflammation did not correlate with serum glucose levels but rather only with long-term glycemic management markers like glycated haemoglobin and fructosamine. Transcatheter aortic valve replacement, which has been shown to be safer than surgical aortic valve replacement, is advantageous for AS patients who also have concurrent diabetes. Additionally, novel anti-diabetic medications have been proposed to lower the risk of AS development in DM patients, including sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonist that target reduction of AGEs-mediated oxidative stress.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There are little data on the effects of hyperglycemia on valvular calcification, but understanding the interactions between them is essential to develop a successful treatment strategy to stop or at least slow the progression of AS in DM patients. There is a link among AS and DM and that DM negatively impacts the quality of life and longevity of AS patients. The sole successful treatment, despite ongoing efforts to find new therapeutic modalities, involves aortic valve replacement. More research is required to find methods that can slow the advancement of these conditions, enhancing the prognosis and course of people with AS and DM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s43044-023-00345-6","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T11:02:58Z","timestamp":1680865378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus"],"prefix":"10.1186","volume":"75","author":[{"given":"Pranay","family":"Wal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namra","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"issue":"1","key":"345_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/heartjnl-2014-307020","volume":"102","author":"S Coffey","year":"2016","unstructured":"Coffey S, Cairns BJ, Iung B (2016) The modern epidemiology of heart valve disease. Heart 102(1):75\u201385","journal-title":"Heart"},{"issue":"5","key":"345_CR2","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/0735-1097(93)90249-Z","volume":"21","author":"M Lindroos","year":"1993","unstructured":"Lindroos M, Kupari M, Heikkila J et al (1993) Prevalence of aortic valve abnormalities in the elderly. An echocardiographic study of a random population sample. J Am Coll Cardiol 21(5):1220\u20131225","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"345_CR3","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.jacc.2016.03.506","volume":"67","author":"GM Deeb","year":"2016","unstructured":"Deeb GM, Reardon MJ, Chetcuti S et al (2016) Core Valve US Clinical Investigators. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol 67(22):2565\u20132574","journal-title":"J Am Coll Cardiol"},{"key":"345_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/CIRCRESAHA.111.300084","volume":"113","author":"BR Lindman","year":"2013","unstructured":"Lindman BR, Bonow RO, Otto CM (2013) Current management of calcific aortic stenosis. Circ Res 113:223\u2013237","journal-title":"Circ Res"},{"key":"345_CR5","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMe0807001","volume":"359","author":"CM Otto","year":"2008","unstructured":"Otto CM (2008) Calcific aortic stenosis\u2014time to look more closely at the valve. New Engl J Med 359:1395\u20131398","journal-title":"New Engl J Med"},{"key":"345_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.amjmed.2016.10.005","volume":"130","author":"J Joseph","year":"2017","unstructured":"Joseph J, Naqvi SY, Giri J, Goldberg S (2017) Aortic stenosis: pathophysiology, diagnosis, and therapy. Am J Med 130:253\u2013263","journal-title":"Am J Med"},{"key":"345_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/heartjnl-2012-302265","volume":"99","author":"GW Eveborn","year":"2013","unstructured":"Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K (2013) The evolving epidemiology of valvular aortic stenosis. The Troms\u00f8 study. Heart 99:396\u2013400","journal-title":"Heart"},{"key":"345_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.111.025270","volume":"124","author":"I Falc\u00e3o-Pires","year":"2011","unstructured":"Falc\u00e3o-Pires I, Hamdani N, Borb\u00e9ly A, Gavina C, Schalkwijk CG, van der Velden J, van Heerebeek L, Stienen G, Niessen HW, Leite-Moreira AF et al (2011) Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. Circulation 124:1151\u20131159","journal-title":"Circulation"},{"issue":"18","key":"345_CR9","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1161\/CIRCULATIONAHA.108.805911","volume":"118","author":"FJ Schoen","year":"2008","unstructured":"Schoen FJ (2008) Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 118(18):1864\u20131880","journal-title":"Circulation"},{"issue":"1","key":"345_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/CIRCINTERVENTIONS.108.780858","volume":"1","author":"N Piazza","year":"2008","unstructured":"Piazza N, de Jaegere P, Schultz C et al (2008) Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 1(1):74\u201381","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"345_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4037\/ccn2013820","volume":"33","author":"T Cary","year":"2013","unstructured":"Cary T, Pearce J (2013) Aortic stenosis: pathophysiology, diagnosis, and medical management of nonsurgical patients. Crit Care Nurse 33(2):58\u201372","journal-title":"Crit Care Nurse"},{"issue":"1484","key":"345_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1098\/rstb.2007.2125","volume":"362","author":"M Misfeld","year":"2007","unstructured":"Misfeld M, Sievers HH (2007) Heart valve macro- and microstructure. Philos Trans R Soc Lond B Biol Sci 362(1484):1421\u20131436","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"11","key":"345_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11936-015-0409-7","volume":"17","author":"R Capoulade","year":"2015","unstructured":"Capoulade R, Pibarot P (2015) Assessment of aortic valve disease: role of imaging modalities. Curr Treat Options Cardiovasc Med 17(11):49","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"345_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11914-009-0008-1","volume":"7","author":"LL Demer","year":"2009","unstructured":"Demer LL, Tintut Y (2009) Mechanisms linking osteoporosis with cardiovascular calcification. Curr Osteoporos Rep 7:42\u201346","journal-title":"Curr Osteoporos Rep"},{"key":"345_CR15","doi-asserted-by":"publisher","first-page":"11201","DOI":"10.1073\/pnas.1932554100","volume":"100","author":"TM Doherty","year":"2003","unstructured":"Doherty TM, Asotra K, Fitzpatrick LA, Qiao JH, Wilkin DJ, Detrano RC, Dunstan CR, Shah PK, Rajavashisth TB (2003) Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci 100:11201\u201311206","journal-title":"Proc Natl Acad Sci"},{"key":"345_CR16","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.107.717512","volume":"117","author":"MP Schenker","year":"2008","unstructured":"Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, Kwong RY, Di Carli MF (2008) Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography computed tomography study. Circulation 117:1693\u20131700","journal-title":"Circulation"},{"key":"345_CR17","doi-asserted-by":"publisher","first-page":"H802","DOI":"10.1152\/ajpheart.00318.2009","volume":"297","author":"T Hoshino","year":"2009","unstructured":"Hoshino T, Chow LA, Hsu JJ, Perlowski AA, Abedin M, Tobis J, Tintut Y, Mal AK, Klug WS, Demer LL (2009) Mechanical stress analysis of a rigid inclusion in distensible material: a model of atherosclerotic calcification and plaque vulnerability. Am J Physiol Heart Circ Physiol 297:H802-810","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"345_CR18","first-page":"37","volume":"5","author":"Y Vengrenyuk","year":"2008","unstructured":"Vengrenyuk Y, Cardoso L, Weinbaum S (2008) Micro-ct based analysis of a new paradigm for vulnerable plaque rupture: cellular microcalcifications in fibrous caps. Mol Cell Biomech 5:37\u201347","journal-title":"Mol Cell Biomech"},{"key":"345_CR19","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1161\/CIRCULATIONAHA.106.657759","volume":"114","author":"NM Rajamannan","year":"2006","unstructured":"Rajamannan NM (2006) Calcific aortic stenosis: a disease ready for prime time. Circulation 114:2007\u20132009","journal-title":"Circulation"},{"key":"345_CR20","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1161\/01.CIR.0000017435.87463.72","volume":"105","author":"NM Rajamannan","year":"2002","unstructured":"Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO, Spelsberg TC (2002) Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105:2660\u20132665","journal-title":"Circulation"},{"key":"345_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jacc.2005.03.058","volume":"46","author":"K Tanaka","year":"2005","unstructured":"Tanaka K, Sata M, Fukuda D, Suematsu Y, Motomura N, Takamoto S, Hirata Y, Nagai R (2005) Age associated aortic stenosis in apolipoprotein e-deficient mice. J Am Coll Cardiol 46:134\u2013141","journal-title":"J Am Coll Cardiol"},{"key":"345_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.105.552844","volume":"113","author":"MA Allison","year":"2006","unstructured":"Allison MA, Cheung P, Criqui MH, Langer RD, Wright CM (2006) Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation 113:861\u2013866","journal-title":"Circulation"},{"key":"345_CR23","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1161\/CIRCULATIONAHA.104.486738","volume":"111","author":"RV Freeman","year":"2005","unstructured":"Freeman RV, Otto CM (2005) Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111:3316\u20133326","journal-title":"Circulation"},{"key":"345_CR24","doi-asserted-by":"publisher","first-page":"S267","DOI":"10.1681\/ASN.2006080925","volume":"17","author":"JB Cannata-Andia","year":"2006","unstructured":"Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N, Naves-Diaz M, Diaz-Lopez B (2006) Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 17:S267-273","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"345_CR25","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1074\/jbc.M115.667576","volume":"291","author":"N Verma","year":"2016","unstructured":"Verma N, Manna SK (2016) Advanced glycation end products (AGE) potently induce autophagy through activation of RAF protein kinase and nuclear factor \u03baB (NF-\u03bab). J Biol Chem 291(3):1481\u20131491","journal-title":"J Biol Chem"},{"issue":"9","key":"345_CR26","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107(9):1058\u20131070","journal-title":"Circ Res"},{"issue":"13","key":"345_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015261","volume":"9","author":"K Saku","year":"2020","unstructured":"Saku K, Tahara N, Takaseya T et al (2020) Pathological role of receptor for advanced glycation end products in calcified aortic valve stenosis. J Am Heart Assoc 9(13):e015261","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"345_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00395-012-0306-0","volume":"107","author":"F Li","year":"2012","unstructured":"Li F, Cai Z, Chen F et al (2012) Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products. Basic Res Cardiol 107(6):306","journal-title":"Basic Res Cardiol"},{"key":"345_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exger.2014.05.001","volume":"59","author":"B Hofmann","year":"2014","unstructured":"Hofmann B, Yakobus Y, Indrasari M et al (2014) RAGE influences the development of aortic valve stenosis in mice on a high fat diet. Exp Gerontol 59:13\u201320","journal-title":"Exp Gerontol"},{"issue":"2","key":"345_CR30","first-page":"352","volume":"102","author":"B Lv","year":"2009","unstructured":"Lv B, Wang H, Tang Y et al (2009) High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1. Thromb Haemost 102(2):352\u2013359","journal-title":"Thromb Haemost"},{"issue":"1","key":"345_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-020-01068-7","volume":"19","author":"M Kopytek","year":"2020","unstructured":"Kopytek M, Z\u0105bczyk M, Mazur P et al (2020) Accumulation of advanced glycationend products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc Diabetol 19(1):92","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"345_CR32","first-page":"845","volume":"39","author":"S Yamagishi","year":"2007","unstructured":"Yamagishi S, Adachi H, Takeuchi M et al (2007) Serum level of advanced glycation end-products (AGEs) is an independent determinant of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic general population. HormMetab Res 39(11):845\u2013848","journal-title":"HormMetab Res"},{"issue":"11","key":"345_CR33","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1007\/s00125-021-05545-w","volume":"64","author":"M Kopytek","year":"2021","unstructured":"Kopytek M, Mazur P, Z\u0105bczyk M et al (2021) Diabetes concomitant to aortic stenosis is associated with increased expression of NF-\u03baB and more pronounced valve calcification. Diabetologia 64(11):2562\u20132574","journal-title":"Diabetologia"},{"key":"345_CR34","first-page":"31","volume-title":"Calcific aortic valve disease","author":"I Tilea","year":"2013","unstructured":"Tilea I, Suciu H, Tilea B et al (2013) Anatomy and function of normal aortic valvular complex. In: Aikawa E (ed) Calcific aortic valve disease. Intechopen, London, pp 31\u201357"},{"key":"345_CR35","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/eurheartj\/ehp287","volume":"30","author":"J Stritzke","year":"2009","unstructured":"Stritzke J, Linsel-Nitschke P, Markus MRP, Mayer B, Lieb W, Luchner A, D\u00f6ring A, Koenig W, Keil U, Hense HW et al (2009) Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA\/MONICA survey. Eur Heart J 30:2044\u20132053","journal-title":"Eur Heart J"},{"key":"345_CR36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2337\/db08-1515","volume":"58","author":"R Katz","year":"2009","unstructured":"Katz R, Budoff MJ, Takasu J, Shavelle DM, Bertoni A, Blumenthal RS, Ouyang P, Wong ND, O\u2019Brien K (2009) Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes 58:813\u2013819","journal-title":"Diabetes"},{"key":"345_CR37","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2017.01.025","volume":"69","author":"AT Yan","year":"2017","unstructured":"Yan AT, Koh M, Chan KK, Guo H, Alter DA, Austin PC, Tu JV, Wijeysundera HC, Ko DT (2017) Association between cardiovascular risk factors and aortic stenosis. J Am Coll Cardiol 69:1523\u20131532","journal-title":"J Am Coll Cardiol"},{"key":"345_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.109.894170","volume":"121","author":"R Rosenhek","year":"2010","unstructured":"Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S, Bergler-Klein J, Grimm M, Gabriel H (2010) Maurer, natural history of very severe aortic stenosis. Circulation 121:151\u2013156","journal-title":"Circulation"},{"key":"345_CR39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamacardio.2018.3152","volume":"3","author":"P Lancellotti","year":"2018","unstructured":"Lancellotti P, Magne J, Dulgheru R, Clavel M-A, Donal E, Vannan MA, Chambers J, Rosenhek R, Habib G, Lloyd G et al (2018) Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics. JAMA Cardiol 3:1060\u20131068","journal-title":"JAMA Cardiol"},{"key":"345_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10557-018-6786-x","volume":"32","author":"E Flores","year":"2018","unstructured":"Flores E, Santos-Gallego CG, Diaz-Mej\u00eda N, Badimon JJ (2018) Do the SGLT-2 inhibitors offer more than hypoglycemic activity? Cardiovasc Drugs Ther 32:213\u2013222","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"345_CR41","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/hrt.2003.029785","volume":"91","author":"NM Rajamannan","year":"2005","unstructured":"Rajamannan NM, Subramaniam M, Stock SR et al (2005) Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 91(6):806\u2013810","journal-title":"Heart"},{"issue":"9","key":"345_CR42","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/hrt.2007.130971","volume":"94","author":"NM Rajamannan","year":"2008","unstructured":"Rajamannan NM (2008) Low-density lipoprotein and aortic stenosis. Heart 94(9):1111\u20131112","journal-title":"Heart"},{"issue":"19","key":"345_CR43","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","volume":"60","author":"MR Dweck","year":"2012","unstructured":"Dweck MR, Boon NA, Newby DE (2012) Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol 60(19):1854\u20131863","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"345_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.carpath.2010.11.007","volume":"20","author":"NM Rajamannan","year":"2011","unstructured":"Rajamannan NM (2011) Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation. Cardiovasc Pathol 20(3):168\u2013176","journal-title":"Cardiovasc Pathol"},{"key":"345_CR45","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","volume":"124","author":"A Wang","year":"2011","unstructured":"Wang A, Bashore TM (2011) Calcific aortic valve disease: not simply a degenerative valvular process. Circulation 124:1783\u20131791","journal-title":"Circulation"},{"issue":"4","key":"345_CR46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/heart.88.4.348","volume":"88","author":"L Wallby","year":"2002","unstructured":"Wallby L, Janerot-Sj\u00a8oberg B, Steffensen T, Broqvist M (2002) T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart 88(4):348\u2013351","journal-title":"Heart"},{"issue":"17","key":"345_CR47","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/01.CIR.0000070591.21548.69","volume":"107","author":"NM Rajamannan","year":"2003","unstructured":"Rajamannan NM, Subramaniam M, Rickard D et al (2003) Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107(17):2181\u20132184","journal-title":"Circulation"},{"issue":"2","key":"345_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0021-9150(03)00284-3","volume":"170","author":"JJ Kaden","year":"2003","unstructured":"Kaden JJ, Dempfle CE, Grobholz R (2003) Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 170(2):205\u2013211","journal-title":"Atherosclerosis"},{"issue":"2","key":"345_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.carpath.2005.01.002","volume":"14","author":"JJ Kaden","year":"2005","unstructured":"Kaden JJ, Dempfle C-E, Grobholz R et al (2005) Inflammatory regulation of extracellular matrix remodelling in calcific aortic valve stenosis. Cardiovasc Pathol 14(2):80\u201387","journal-title":"Cardiovasc Pathol"},{"issue":"9","key":"345_CR50","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.jacc.2004.07.054","volume":"44","author":"S Helske","year":"2004","unstructured":"Helske S, Lindstedt KA, Laine M et al (2004) Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol 44(9):1859\u20131866","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"345_CR51","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/archinte.165.8.858","volume":"165","author":"KD O\u2019Brien","year":"2005","unstructured":"O\u2019Brien KD, Probstfield JL, Caulfield MT et al (2005) Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 165(8):858\u2013862","journal-title":"Arch Intern Med"},{"issue":"10","key":"345_CR52","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/01.CIR.0000140723.15274.53","volume":"110","author":"R Rosenhek","year":"2004","unstructured":"Rosenhek R, Rader F, Loho N et al (2004) Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis. Circulation 110(10):1291\u20131295","journal-title":"Circulation"},{"issue":"6","key":"345_CR53","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/heart.85.6.635","volume":"85","author":"JR Ortlepp","year":"2001","unstructured":"Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P (2001) The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 85(6):635\u2013638","journal-title":"Heart"},{"issue":"14","key":"345_CR54","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jacc.2007.12.031","volume":"51","author":"Y Boss\u00b4e","year":"2008","unstructured":"Boss\u00b4e Y, Mathieu P, Pibarot P (2008) Genomics the next step to elucidate the etiology of calcific aortic valve stenosis. J Am Coll Cardiol 51(14):1327\u20131336","journal-title":"J Am Coll Cardiol"},{"key":"345_CR55","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1148\/radiol.2263020338","volume":"226","author":"WA Murphy Jr","year":"2003","unstructured":"Murphy WA Jr, Nedden DZ, Gostner P, Knapp R, Recheis W, Seidler H (2003) The iceman: discovery and imaging. Radiology 226:614\u2013629","journal-title":"Radiology"},{"issue":"11","key":"345_CR56","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.110.234138","volume":"108","author":"JD Miller","year":"2011","unstructured":"Miller JD, Weiss RM, Heistad DD (2011) Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res 108(11):1392\u20131412","journal-title":"Circ Res"},{"issue":"4","key":"345_CR57","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/HCO.0000000000000300","volume":"31","author":"C Yeang","year":"2016","unstructured":"Yeang C, Wilkinson MJ, Tsimikas S (2016) Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis. Curr Opin Cardiol 31(4):440\u2013450","journal-title":"Curr Opin Cardiol"},{"issue":"1","key":"345_CR58","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2014.04.013","volume":"235","author":"JR Kizer","year":"2014","unstructured":"Kizer JR, Benkeser D, Arnold AM et al (2014) Advanced glycation\/glycoxidation end product carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults. Atherosclerosis 235(1):116\u2013121","journal-title":"Atherosclerosis"},{"issue":"2","key":"345_CR59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1586\/erc.12.171","volume":"11","author":"F Akerstrom","year":"2013","unstructured":"Akerstrom F, Barderas MG, Rodriguez-Padial L (2013) Aortic stenosis: a general overview of clinical, pathophysiological and therapeutic aspects. Expert Rev Cardiovasc Ther 11(2):239\u2013250","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"345_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijcard.2009.03.108","volume":"135","author":"E Yetkin","year":"2009","unstructured":"Yetkin E, Waltenberger J (2009) Molecular and cellular mechanisms of aortic stenosis. Int J Cardiol 135(1):4\u201313","journal-title":"Int J Cardiol"},{"issue":"3","key":"345_CR61","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1016\/j.ijcard.2013.01.207","volume":"168","author":"E Nagy","year":"2013","unstructured":"Nagy E, Eriksson P, Yousry M et al (2013) Valvular osteoclasts in calcification and aortic valve stenosis severity. Int J Cardiol 168(3):2264\u20132271","journal-title":"Int J Cardiol"},{"issue":"5","key":"345_CR62","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jacc.2015.05.066","volume":"66","author":"TA Pawade","year":"2015","unstructured":"Pawade TA, Newby DE, Dweck MR (2015) Calcification in aortic stenosis: the skeleton key. J Am Coll Cardiol 66(5):561\u2013577","journal-title":"J Am Coll Cardiol"},{"key":"345_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fcvm.2018.00021","volume":"5","author":"A Hulin","year":"2018","unstructured":"Hulin A, Hego A, Lancellotti P, Oury C (2018) Advances in pathophysiology of calcific aortic valve disease propose novel molecular therapeutic targets. Front Cardiovasc Med 5:21","journal-title":"Front Cardiovasc Med"},{"key":"345_CR64","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/eurheartj\/ehx653","volume":"39","author":"FECM Peeters","year":"2018","unstructured":"Peeters FECM, Meex SJR, Dweck MR, Aikawa E, Crijns HJGM, Schurgers LJ, Kietselaer BLJH (2018) Calcific aortic valve stenosis: hard disease in the heart: a biomolecular approach towards diagnosis and treatment. Eur Heart J 39:2618\u20132624","journal-title":"Eur Heart J"},{"key":"345_CR65","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/cphy.c160020","volume":"7","author":"GL Perrucci","year":"2017","unstructured":"Perrucci GL, Zanobini M, Gripari P, Songia P, Alshaikh B, Tremoli E, Poggio P (2017) Pathophysiology of aortic stenosis and mitral regurgitation. Compr Physiol 7:799\u2013818","journal-title":"Compr Physiol"},{"key":"345_CR66","doi-asserted-by":"crossref","unstructured":"Tao G, Kotick JD, Lincoln J (2012) Heart valve development, maintenance, and disease. In: The role of endothelial cells, vol. 2. Elsevier Inc., Amsterdam, p 100","DOI":"10.1016\/B978-0-12-387786-4.00006-3"},{"key":"345_CR67","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006339","volume":"6","author":"A Rutkovskiy","year":"2017","unstructured":"Rutkovskiy A, Malashicheva A, Sullivan G, Bogdanova M, Kostareva A, Stensl\u00f8kken KO, Fiane A, Vaage J (2017) Valve interstitial cells: the key to understanding the pathophysiology of heart valve calcification. J Am Heart Assoc 6:e006339","journal-title":"J Am Heart Assoc"},{"key":"345_CR68","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jacc.2015.05.066","volume":"66","author":"TA Pawade","year":"2015","unstructured":"Pawade TA, Newby DE, Dweck MR (2015) Calcification in aortic stenosis: the skeleton key. J Am Coll Cardiol 66:561\u2013577","journal-title":"J Am Coll Cardiol"},{"key":"345_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yjmcc.2003.09.015","volume":"36","author":"JJ Kaden","year":"2004","unstructured":"Kaden JJ, Bickelhaupt S, Grobholz R, Haase KK, Sariko\u00e7 A, Kili\u00e7 R, Brueckmann M, Lang S, Zahn I, Vahl C et al (2004) Receptor activator of nuclear factor _B ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 36:57\u201366","journal-title":"J Mol Cell Cardiol"},{"key":"345_CR70","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.yjmcc.2012.02.003","volume":"52","author":"N C\u00f4t\u00e9","year":"2012","unstructured":"C\u00f4t\u00e9 N, El Husseini D, P\u00e9pin A, Guauque-Olarte S, Ducharme V, Bouchard-Cannon P, Audet A, Fournier D, Gaudreault N, Derbali H et al (2012) ATP acts as a survival signal and prevents the mineralization of aortic valve. J Mol Cell Cardiol 52:1191\u20131202","journal-title":"J Mol Cell Cardiol"},{"key":"345_CR71","doi-asserted-by":"publisher","first-page":"20366","DOI":"10.1002\/jcp.28638","volume":"234","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Li J, Zhou K, Liao X, Zhou X, Shen K (2019) The methylation of Notch1 promoter mediates the osteogenesis differentiation in human aortic valve interstitial cells through Wnt\/\u03b2-catenin signalling. J Cell Physiol 234:20366\u201320376","journal-title":"J Cell Physiol"},{"key":"345_CR72","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/ATVBAHA.108.174342","volume":"28","author":"M Rattazzi","year":"2008","unstructured":"Rattazzi M, Iop L, Faggin E, Bertacco E, Zoppellaro G, Baesso I, Puato M, Torregrossa G, Fadini GP, Agostini C et al (2008) Clones of interstitial cells from bovine aortic valve exhibit di_erent calcifying potential when exposed to endotoxin and phosphate. Arterioscler Thromb Vasc Biol 28:2165\u20132172","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"345_CR73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fcvm.2018.00187","volume":"5","author":"MC Blaser","year":"2018","unstructured":"Blaser MC, Aikawa E (2018) Roles and regulation of extracellular vesicles in cardiovascular mineral metabolism. Front Cardiovasc Med 5:187","journal-title":"Front Cardiovasc Med"},{"key":"345_CR74","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/eurpub\/cky098","volume":"29","author":"MC Johnston","year":"2019","unstructured":"Johnston MC, Crilly M, Black C, Prescott G, Mercer SW (2019) Defining and measuring multimorbidity: a systematic review of systematic reviews. Eur J Public Health 29:182\u2013189","journal-title":"Eur J Public Health"},{"key":"345_CR75","doi-asserted-by":"publisher","first-page":"e0246623","DOI":"10.1371\/journal.pone.0246623","volume":"16","author":"DLB De Souza","year":"2021","unstructured":"De Souza DLB, Oliveras-Fabregas A, Espelt A, Bosque-Prous M, Cancela MDC, Teixid\u00f3-Compa\u00f1\u00f3 E, Jerez-Roig J (2021) Multimorbidity and its associated factors among adults aged 50 and over: a cross-sectional study in 17 European countries. PLoS ONE 16:e0246623","journal-title":"PLoS ONE"},{"key":"345_CR76","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2020-001271","volume":"7","author":"TK Rudolph","year":"2020","unstructured":"Rudolph TK, Messika-Zeitoun D, Frey N, Thambyrajah J, Serra A, Schulz E, Maly J, Aiello M, Lloyd G, Bortone AS et al (2020) Impact of selected comorbidities on the presentation and management of aortic stenosis. Open Heart 7:e001271","journal-title":"Open Heart"},{"key":"345_CR77","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","volume":"6","author":"BM Leon","year":"2015","unstructured":"Leon BM (2015) Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 6:1246\u20131258","journal-title":"World J Diabetes"},{"key":"345_CR78","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cjca.2012.01.017","volume":"28","author":"AC Montezano","year":"2012","unstructured":"Montezano AC, Touyz RM (2012) Molecular mechanisms of hypertension\u2014reactive oxygen species and antioxidants: a basic science update for the clinician. Can J Cardiol 28:288\u2013295","journal-title":"Can J Cardiol"},{"key":"345_CR79","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MED.0000000000000471","volume":"26","author":"HY Chen","year":"2019","unstructured":"Chen HY, Engert JC, Thanassoulis G (2019) Risk factors for valvular calcification. Curr Opin Endocrinol Diabetes Obes 26:96\u2013102","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"345_CR80","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/HJH.0000000000002426","volume":"38","author":"S Saeed","year":"2020","unstructured":"Saeed S, Scalise F, Chambers JB, Mancia G (2020) Hypertension in aortic stenosis: a focused review and recommendations for clinical practice. J Hypertens 38:1211\u20131219","journal-title":"J Hypertens"},{"key":"345_CR81","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","volume":"359","author":"AB Rosseb\u00f8","year":"2008","unstructured":"Rosseb\u00f8 AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-B\u00e4rwolf C, Holme I, Kes\u00e4niemi YA et al (2008) Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359:1343\u20131356","journal-title":"N Engl J Med"},{"key":"345_CR82","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, Adebayo OM, Afarideh M, Agarwal SK, Agudelo-Botero M et al (2020) Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395:709\u2013733","journal-title":"Lancet"},{"key":"345_CR83","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017190","volume":"9","author":"Y Bohbot","year":"2020","unstructured":"Bohbot Y, Candellier A, Diouf M, Rusinaru D, Altes A, Pasquet A, Mar\u00e9chaux S, Vanoverschelde J, Tribouilloy C (2020) Severe aortic stenosis and chronic kidney disease: outcomes and impact of aortic valve replacement. J Am Heart Assoc 9:e017190","journal-title":"J Am Heart Assoc"},{"key":"345_CR84","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40842-015-0001-9","volume":"1","author":"AJ Hahr","year":"2015","unstructured":"Hahr AJ, Molitch ME (2015) Management of diabetes mellitus in patients with chronic kidney disease. Clin Diabetes Endocrinol 1:2","journal-title":"Clin Diabetes Endocrinol"},{"key":"345_CR85","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/0976-9668.149117","volume":"6","author":"R Garg","year":"2015","unstructured":"Garg R, Aggarwal S, Kumar R, Sharma G (2015) Association of atherosclerosis with dyslipidemia and co-morbid conditions: a descriptive study. J Nat Sci Biol Med 6:163\u2013168","journal-title":"J Nat Sci Biol Med"},{"key":"345_CR86","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jacc.2013.05.047","volume":"62","author":"JG Dumesnil","year":"2015","unstructured":"Dumesnil JG, Pibarot P (2015) The obesity paradox in aortic stenosis. J Am Coll Cardiol 62:1691\u20131693","journal-title":"J Am Coll Cardiol"},{"key":"345_CR87","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jacc.2019.10.050","volume":"75","author":"M Kaltoft","year":"2002","unstructured":"Kaltoft M, Langsted A, Nordestgaard BG (2002) Obesity as a causal risk factor for aortic valve stenosis. J Am Coll Cardiol 75:163\u2013176","journal-title":"J Am Coll Cardiol"},{"key":"345_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3042","volume":"34","author":"A Chobot","year":"2018","unstructured":"Chobot A, G\u00f3rowska-Kowolik K, Soko\u0142owska M, Jarosz-Chobot P (2018) Obesity and diabetes-not only a simple link between two epidemics. Diabetes Metab Res Rev 34:e3042","journal-title":"Diabetes Metab Res Rev"},{"key":"345_CR89","doi-asserted-by":"publisher","first-page":"370","DOI":"10.12688\/f1000research.17122.1","volume":"8","author":"CA Aguilar-Salinas","year":"2019","unstructured":"Aguilar-Salinas CA, Viveros-Ruiz T (2019) Recent advances in managing\/understanding the metabolic syndrome. F1000Research 8:370","journal-title":"F1000Research"},{"key":"345_CR90","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jacc.2012.03.052","volume":"60","author":"R Capoulade","year":"2012","unstructured":"Capoulade R, Clavel M-A, Dumesnil JG, Chan KL, Teo KK, Tam JW, C\u00f4t\u00e9 N, Mathieu P, Despr\u00e9s J-P, Pibarot P (2012) I impact of metabolic syndrome on progression of aortic stenosis. J Am Coll Cardiol 60:216\u2013223","journal-title":"J Am Coll Cardiol"},{"key":"345_CR91","first-page":"2313","volume":"10","author":"M-K Lee","year":"2020","unstructured":"Lee M-K, Han K, Kim MK, Koh ES, Kim ES, Nam GE, Kwon H-S (2020) Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study. Sci 10:2313","journal-title":"Sci"},{"issue":"3","key":"345_CR92","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s10753-011-9384-7","volume":"35","author":"J Natorska","year":"2012","unstructured":"Natorska J, Wypasek E, Grudzie\u0144 G et al (2012) Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves? Inflammation 35(3):834\u2013840","journal-title":"Inflammation"},{"key":"345_CR93","doi-asserted-by":"crossref","unstructured":"Nishimura RA (2014) AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary. a report of the American college of cardiology\/American heart association task force on practice guidelines. Circulation","DOI":"10.1161\/CIR.0000000000000029"},{"key":"345_CR94","unstructured":"Elster (2006) ACCF\/ACR\/SCCT\/SCMR\/ASNC\/NASCI\/SCAI\/SIR. appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 48:9775\u20139797"},{"issue":"4","key":"345_CR95","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.ehj.2004.06.040","volume":"25","author":"D Pennell","year":"2004","unstructured":"Pennell D, Sechtem U, Higgins C et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): consensus Panel report. Eur Heart J 25(4):1940\u20131946","journal-title":"Eur Heart J"},{"issue":"3","key":"345_CR96","doi-asserted-by":"publisher","first-page":"259","DOI":"10.21037\/qims.2016.06.05","volume":"6","author":"TA Musa","year":"2016","unstructured":"Musa TA, Plein S, Greenwood JP (2016) The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement. Quant Imaging Med Surg 6(3):259\u2013273","journal-title":"Quant Imaging Med Surg"},{"issue":"9","key":"345_CR97","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cjca.2014.04.021","volume":"30","author":"CWL Chin","year":"2014","unstructured":"Chin CWL, Khaw HJ, Luo E et al (2014) Echocardiography underestimates stroke volume and aortic valve area: implications for patients with small-area low-gradient aortic stenosis. Can J Cardiol 30(9):1064\u20131072","journal-title":"Can J Cardiol"},{"issue":"9","key":"345_CR98","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0009-9260(03)00184-3","volume":"58","author":"SJ Cowell","year":"2003","unstructured":"Cowell SJ, Newby DE, Burton J et al (2003) Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin Radiol 58(9):712\u2013716","journal-title":"Clin Radiol"},{"key":"345_CR99","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","volume":"49","author":"LM Moura","year":"2007","unstructured":"Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Gon\u00e7alves F, Rajamannan NM (2007) Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 49:554\u2013561","journal-title":"J Am Coll Cardiol"},{"key":"345_CR100","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1148\/radiol.2263020338","volume":"226","author":"WA Murphy Jr","year":"2003","unstructured":"Murphy WA Jr, NeddenDz D, Gostner P, Knapp R, Recheis W, Seidler H (2003) The iceman: discovery and imaging. Radiology 226:614\u2013629","journal-title":"Radiology"},{"issue":"2","key":"345_CR101","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.carpath.2005.01.002","volume":"14","author":"JJ Kaden","year":"2005","unstructured":"Kaden JJ, Dempfle C-E, Grobholz R et al (2005) Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 14(2):80\u201387","journal-title":"Cardiovasc Pathol"},{"key":"345_CR102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40265-014-0337-y","volume":"75","author":"AJ Scheen","year":"2015","unstructured":"Scheen AJ (2015) Pharmacodynamics, efficacy and safety of sodium\u2013glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus. Drugs 75:33\u201359","journal-title":"Drugs"},{"key":"345_CR103","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.2147\/DDDT.S69926","volume":"9","author":"JH Shubrook","year":"2015","unstructured":"Shubrook JH, Bokaie BB, Adkins SE (2015) Empagliflozin in the treatment of type 2 diabetes: evidence to date. Drug Des Dev Ther 9:5793\u20135803","journal-title":"Drug Des Dev Ther"},{"key":"345_CR104","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4137\/CMED.S31526","volume":"8","author":"C Triplitt","year":"2015","unstructured":"Triplitt C, Cornell S (2015) Canagliflozin treatment in patients with type 2 diabetes mellitus. Clin Med Insights Endocrinol Diabetes 8:73\u201381","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"345_CR105","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett DH, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117\u20132128","journal-title":"N Engl J Med"},{"key":"345_CR106","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, Von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375:323\u2013334","journal-title":"N Engl J Med"},{"key":"345_CR107","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/1479164118820657","volume":"16","author":"M Banovic","year":"2019","unstructured":"Banovic M, Athithan L, McCann GP (2019) Aortic stenosis and diabetes mellitus: an ominous combination. Diabetes Vasc Dis Res 16:310\u2013323","journal-title":"Diabetes Vasc Dis Res"},{"key":"345_CR108","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.athoracsur.2010.03.111","volume":"90","author":"ME Halkos","year":"2010","unstructured":"Halkos ME, Kilgo P, Lattouf OM, Puskas JD, Cooper WA, Guyton RA, Thourani VH (2010) The effect of diabetes mellitus on in-hospital and long-term outcomes after heart valve operations. Ann Thorac Surg 90:124\u2013130","journal-title":"Ann Thorac Surg"},{"key":"345_CR109","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.hlc.2015.05.019","volume":"25","author":"T Nakamura","year":"2016","unstructured":"Nakamura T, Toda K, Kuratani T, Miyagawa S, Yoshikawa Y, Fukushima S, Saito S, Yoshioka D, Kashiyama N, Daimon T et al (2016) Diabetes mellitus impairs left ventricular mass regression after surgical or transcatheter aortic valve replacement for severe aortic stenosis. Heart Lung Circ 25:68\u201374","journal-title":"Heart Lung Circ"},{"issue":"6","key":"345_CR110","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/ageing\/afh175","volume":"33","author":"SJ Cowell","year":"2004","unstructured":"Cowell SJ, Newby DE, Boon NA, Elder AT (2004) Calcific aortic stenosis: Same old story? Age Ageing 33(6):538\u2013544","journal-title":"Age Ageing"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00345-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-023-00345-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-023-00345-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T12:03:32Z","timestamp":1680869012000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-023-00345-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["345"],"URL":"https:\/\/doi.org\/10.1186\/s43044-023-00345-6","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"11 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}